 |
市場調查報告書
商品編碼
2075399
急救吸入器市場：依產品類型、適應症、患者類型、劑型、最終用戶和地區分類Rescue Inhaler Market, By Product Type, By Indication, By Patient Type, By Dosage Form, By End User, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，急救吸入器市場規模將達到 217.5 億美元，到 2033 年將達到 397.5 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 9.0%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2025 | 市場規模（2026 年） | 217.5億美元 |
| 效能數據 | 2020-2024 | 預測期 | 2026-2033 |
| 預測期（2026-2033 年）複合年成長率 | 9.00% | 預計金額（2033 年） | 397.5億美元 |
急救吸入器（也稱為速效吸入器）是治療氣喘、慢性阻塞性肺病（COPD）等呼吸系統疾病的常用醫療設備。這些吸入器含有速效支氣管擴張劑，有助於在氣喘發作或呼吸困難時擴張氣道。藥物能迅速緩解喘息、呼吸困難和胸悶等症狀。雖然急救吸入器可以快速緩解症狀，但並不能治療疾病的根本原因。它們是控制急性呼吸道症狀、提升患者生活品質的重要工具。
市場動態：
呼吸系統疾病盛行率上升、人口老化以及醫療保健成本不斷增加，預計將推動全球急救吸入器市場在預測期內成長。此外，技術進步預計也將促進全球急救吸入器市場在預測期內的成長。新興市場的高成長潛力、對居家照護環境需求的不斷成長、用於氣喘治療的生物製藥的研發以及呼吸系統治療領域對遠距遠端醫療日益成長的關注，預計都將為全球急救吸入器市場在預測期內創造成長機會。
然而，嚴格的監管要求、吸入器的副作用以及吸入器的高成本預計將在預測期內阻礙緊急吸入器市場的成長。
本報告的主要特點：
- 本報告揭示了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本報告還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本報告根據以下參數對緊急吸入器市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 這份「緊急吸入器市場報告」旨在為該行業的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過利用緊急吸入器市場分析中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 呼吸系統疾病盛行率增加
- 老年人口增加
- 產品核可數量增加
- 抑制因子
- 嚴格的監管要求
- 產品召回
- 吸入器價格高昂
- 機會
- 遠端醫療在呼吸系統治療領域正受到越來越多的關注。
- 開發用於氣喘治療的生物製藥
- 新興市場具有高成長潛力
- 促進因素
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特五力分析
- 併購情景
第4章 緊急吸入器
- 供給面和需求面分析
- 經濟影響
第5章 急救吸入器市場：依產品類型分類（2021-2033 年）
- 定量噴霧吸入器
- 乾粉吸入器
- 噴霧器
- 緩霧吸入器
- 其他
第6章：急救吸入器市場：依適應症分類（2021-2033 年）
- 氣喘
- COPD
- 過敏性鼻炎
- 肺動脈高壓
- 其他
第7章：急救吸入器市場：依病患類型分類（2021-2033 年）
- 成人
- 兒童
第8章：急救吸入器市場：依劑型分類（2021-2033 年）
- 膠囊
- 解決方案
- 懸浮液
- 其他
第9章：急救吸入器市場：按最終用戶分類（2021-2033 年）
- 居家醫療
- 醫院和診所
第10章：急救吸入器市場：按地區分類（2021-2033 年）
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 北非
- 南非
- 中非
第11章 競爭格局
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- OMRON Healthcare Co., Ltd.
- Koninklijke Philips NV
- Invacare
- Schiller
- Teleflex Incorporated
第12章
- 分析方法
- 關於 Coherent Market Insights
簡介目錄
Product Code: CMI6208
Rescue Inhaler Market is estimated to be valued at USD 21.75 Bn in 2026 and is expected to reach USD 39.75 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.0% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 21.75 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.00% | 2033 Value Projection: | USD 39.75 Bn |
A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.
Market Dynamics:
Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.
However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market
Rescue Inhaler Market Detailed Segmentation:
- By Product Type (Revenue, USD Bn, 2021 - 2033)
- Metered Dose Inhalers
- Dry Powder Inhalers
- Nebulizers
- Soft Mist Inhalers
- Others
- By Indication (Revenue, USD Bn, 2021 - 2033)
- Asthma
- COPD
- Allergic Rhinitis
- Pulmonary Arterial Hypertension
- Others
- By Patient Type (Revenue, USD Bn, 2021 - 2033)
- Adult
- Pediatric
- By Dosage Form (Revenue, USD Bn, 2021 - 2033)
- Capsules
- Solution
- Suspension
- Others
- By End User (Revenue, USD Bn, 2021 - 2033)
- Home Care Settings
- Hospitals & Clinics
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profile:
- GSK plc.
- Teva Pharmaceutical Industries Ltd.
- Cipla Inc.
- PARI Pharma GmbH
- Lupin
- AstraZeneca
- Boehringer Ingelheim International GmbH.
- Novartis
- Pfizer
- Sunovion Pharmaceuticals
- 3M
- Omron Healthcare
- Koninklijke Philips N.V.
- Invacare
- Schiller
- Teleflex Incorporated
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By Patient Type
- Market Snippet, By Dosage Form
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising prevalence of respiratory diseases
- Increasing geriatric population
- Increasing Product Approval
- Restraints
- Stringent regulatory requirements
- Product Recall
- High cost of inhalers
- Opportunities
- Rising focus on telehealth for respiratory care
- Development of biologics for asthma
- High growth potential in emerging markets
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Rescue Inhaler
- Supply Side and Demand Side Analysis
- Economic Impact
5. Rescue Inhaler Market, By Product Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Metered Dose Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Dry Powder Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Soft Mist Inhalers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
6. Rescue Inhalers Market, By Indication, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- COPD
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Pulmonary Arterial Hypertension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
7. Rescue Inhalers Market, By Patient Type, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
8. Rescue Inhalers Market, By Dosage Form, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Solution
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Suspension
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
9. Rescue Inhalers Market, By End User, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
10. Rescue Inhalers Market, By Region, 2021 - 2033, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022 €"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
- North Africa
- South Africa
- Central Africa
11. Competitive Landscape
- GSK plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PARI Pharma GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lupin
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Novartis
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Pfizer
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sunovion Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- 3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- OMRON Healthcare Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Invacare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Schiller
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
成人乾粉吸入器市場：全球市場預測，2026-2032年
MDI 和 DPI 市場規模、佔有率和成長分析：按產品類型、適應症、藥物分類、分銷管道、最終用戶和地區分類—2026-2033 年行業預測
乾粉吸入器市場規模、佔有率和成長分析：按產品類型、治療方法、適應症、技術、分銷管道、最終用戶和地區分類－2026-2033年產業預測
Ceritinib市場規模、佔有率和成長分析：按類型、治療應用、用途、最終用戶、分銷管道和地區分類 - 行業預測，2026-2033 年
2026年全球緩霧吸入器市場報告Budesonide和Budesonide吸入粉劑市場按產品類型、適應症、劑量強度和分銷管道分類 - 全球預測 2026-2032Ceritinib膠囊市場按治療領域、最終用戶和分銷管道分類 - 全球預測 2026-2032氟聚合物乾粉市場按產品類型、應用和通路分類－2026-2032年全球預測
全球緩霧吸入器市場
2026 年至 2032 年乾粉吸入器 (DPI) 市場按產品類型、應用、銷售管道和地區分類